Software architecture for customized physical exercise prescription

En la actualidad existe una gran cantidad de aplicaciones para la realización de ejercicio físico. En este artículo se presenta una arquitectura software para una aplicación que permite la prescripción de ejercicios físicos personalizados. Esta arquitectura incluye dos funcionalidades, la funcionalidad para el especialista que prescribe el ejercicio y la funcionalidad para el usuario que debe seguir esta prescripción. La interacción entre el especialista y el usuario se realiza mediante el envío de eventos. Especialistas (médicos/fisioterapeutas/educadores físicos) pueden indicar los ejercicios adecuados en cada caso. Esta aplicación permitirá a los usuarios con demanda de atención personalizada mejorar la condición física y la calidad de vida. Los usuarios podrán realizar el ejercicio físico de forma autónoma, sin tener que realizar desplazamientos y en un horario flexible.Currently there is a lot of available applications to do physical exercise. This article describes the software architecture for an application that allows customized exercise prescription. This architecture includes two functionalities, the functionality that allows specialists to prescribe physical exercises and the functionality for users who must follow this prescription. Interactions between specialists and users are allowed by means of sending events. Specialists (doctors, physiotherapists and physical educators) can indicate appropriate exercises in each case. This application will allow users with demand for personalized attention to improve their fitness and quality of life. Users can perform physical exercise autonomously, without having to travel and in a flexible schedule

Computer labs on virtual environments: A flexible, portable and multidisciplinary model

Teaching of computer-aided practical subjects in engineering education creates new challenges. Computers have to be configured to support particular requirements of each subject. Virtual Environments allows the building of a Virtual Machine (VM) tailored to requirements of each subject, allowing flexible, versatile and low cost laboratories. However, the use of multiple VM at a shared computing facility creates new problems, both technical and related to the performance of the class sessions. To solve these challenges, we have developed the Virtual Machine on-Demand (VMoD) tool. It automates the adaptation of each VM to the environment in which it is deployed and simplifies its use to students. As a result, the creation of computer-aided engineering laboratories on a shared computing facility using VM is possible and profitable

On the Detection Capabilities of Signature-Based Intrusion Detection Systems in the Context of Web Attacks

Signature-based Intrusion Detection Systems (SIDS) play a crucial role within the arsenal of security components of most organizations. They can find traces of known attacks in the network traffic or host events for which patterns or signatures have been pre-established. SIDS include standard packages of detection rulesets, but only those rules suited to the operational environment should be activated for optimal performance. However, some organizations might skip this tuning process and instead activate default off-the-shelf rulesets without understanding its implications and trade-offs. In this work, we help gain insight into the consequences of using predefined rulesets in the performance of SIDS. We experimentally explore the performance of three SIDS in the context of web attacks. In particular, we gauge the detection rate obtained with predefined subsets of rules for Snort, ModSecurity and Nemesida using seven attack datasets. We also determine the precision and rate of alert generated by each detector in a real-life case using a large trace from a public webserver. Results show that the maximum detection rate achieved by the SIDS under test is insufficient to protect systems effectively and is lower than expected for known attacks. Our results also indicate that the choice of predefined settings activated on each detector strongly influences its detection capability and false alarm rate. Snort and ModSecurity scored either a very poor detection rate (activating the less-sensitive predefined ruleset) or a very poor precision (activating the full ruleset). We also found that using various SIDS for a cooperative decision can improve the precision or the detection rate, but not both. Consequently, it is necessary to reflect upon the role of these open-source SIDS with default configurations as core elements for protection in the context of web attacks. Finally, we provide an efficient method for systematically determining which rules deactivate from a ruleset to significantly reduce the false alarm rate for a target operational environment. We tested our approach using Snort’s ruleset in our real-life trace, increasing the precision from 0.015 to 1 in less than 16 h of work. View Full-TextMinisterio de Ciencias e Innovación (MICINN)/AEI 10.13039/501100011033: PID2020-115199RB-I00FEDER/Junta de Andalucía-Consejería de Transformación Económica, Industria, Conocimiento y Universidades PYC20-RE-087-US

Revisión de la exposición en cursos de ingeniería

Se ha realizado una observación sobre los diferentes aspectos de la docencia en su expresión oral. A través de reuniones periódicas se han analizado las ventajas e inconvenientes de cambios metodológicos (problemas resueltos, servicios Web, mantenimiento del orden en la clase, etc.). También se han comentado las grabaciones de clases realizadas en el grupo. Las reuniones mantenidas así como las clases de formación recibidas se han traducido en una experiencia enriquecedora para los profesores noveles, estimando como muy positivos los resultados obtenidos.A number of aspects in oral-teaching have been observed. By means of periodic meetings, the benefits and drawbacks of methodological changes have been analyzed (examination material, web services, discipline problems, etc ... ). Also, the video material recorded about lectures in live has been discussed. The meetings and the lectures and material received in the beginning of this program have resulted into an enhancement of the sort-experienced teachers. The teachers declared a high degree of satisfaction with the results obtained

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

(1) Aims: Patients receiving antitumor necrosis factor (anti-TNF) therapy are at risk of developing tuberculosis (TB), usually due to the reactivation of a latent TB infection (LTBI). LTBI screening and treatment decreases the risk of TB. This study evaluated the diagnostic performance of different LTBI screening strategies in patients with inflammatory bowel disease (IBD). (2) Methods: Patients in the Spanish ENEIDA registry with IBD screened for LTBI between January 2003 and January 2018 were included. The diagnostic yield of different strategies (dual screening with tuberculin skin test [TST] and interferon-gamma-release assay [IGRA], two-step TST, and early screening performed at least 12 months before starting biological treatment) was analyzed. (3) Results: Out of 7594 screened patients, 1445 (19%; 95% CI 18-20%) had LTBI. Immunomodulator (IMM) treatment at screening decreased the probability of detecting LTBI (20% vs. 17%, p = 0.001). Regarding screening strategies, LTBI was more frequently diagnosed by dual screening than by a single screening strategy (IGRA, OR 0.60; 95% CI 0.50-0.73, p < 0.001; TST, OR 0.76; 95% CI 0.66-0.88, p < 0.001). Two-step TST increased the diagnostic yield of a single TST by 24%. More cases of LTBI were diagnosed by early screening than by routine screening before starting anti-TNF agents (21% [95% CI 20-22%] vs. 14% [95% CI 13-16%], p < 0.001). The highest diagnostic performance for LTBI (29%) was obtained by combining early and TST/IGRA dual screening strategies in patients without IMM. (4): Conclusions: Both early screening and TST/IGRA dual screening strategies significantly increased diagnostic performance for LTBI in patients with IBD, with optimal performance achieved when they are used together in the absence of IMM

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

BackgroundPrevious studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain. MethodsProspective, observational, multicenter study comparing cohorts of IBD patients from ENEIDA-registry who were born outside Spain with a cohort of native patients. ResultsWe included 13,524 patients (1,864 immigrant and 11,660 native). The immigrants were younger (45 +/- 12 vs. 54 +/- 16 years, p < 0.001), had been diagnosed younger (31 +/- 12 vs. 36 +/- 15 years, p < 0.001), and had a shorter disease duration (14 +/- 7 vs. 18 +/- 8 years, p < 0.001) than native patients. Family history of IBD (9 vs. 14%, p < 0.001) and smoking (30 vs. 40%, p < 0.001) were more frequent among native patients. The most prevalent ethnic groups among immigrants were Caucasian (41.5%), followed by Latin American (30.8%), Arab (18.3%), and Asian (6.7%). Extraintestinal manifestations, mainly musculoskeletal affections, were more frequent in immigrants (19 vs. 11%, p < 0.001). Use of biologics, mainly anti-TNF, was greater in immigrants (36 vs. 29%, p < 0.001). The risk of having extraintestinal manifestations [OR: 2.23 (1.92-2.58, p < 0.001)] and using biologics [OR: 1.13 (1.0-1.26, p = 0.042)] was independently associated with immigrant status in the multivariate analyses. ConclusionsCompared with native-born patients, first-generation-immigrant IBD patients in Spain were younger at disease onset and showed an increased risk of having extraintestinal manifestations and using biologics. Our study suggests a featured phenotype of immigrant IBD patients in Spain, and constitutes a new landmark in the epidemiological characterization of immigrant IBD populations in Southern Europe

Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry

Aim To determine whether healthcare workers (HCW) hospitalized in Spain due to COVID-19 have a worse prognosis than non-healthcare workers (NHCW). Methods Observational cohort study based on the SEMI-COVID-19 Registry, a nationwide registry that collects sociodemographic, clinical, laboratory, and treatment data on patients hospitalised with COVID-19 in Spain. Patients aged 20-65 years were selected. A multivariate logistic regression model was performed to identify factors associated with mortality. Results As of 22 May 2020, 4393 patients were included, of whom 419 (9.5%) were HCW. Median (interquartile range) age of HCW was 52 (15) years and 62.4% were women. Prevalence of comorbidities and severe radiological findings upon admission were less frequent in HCW. There were no difference in need of respiratory support and admission to intensive care unit, but occurrence of sepsis and in-hospital mortality was lower in HCW (1.7% vs. 3.9%; p = 0.024 and 0.7% vs. 4.8%; p<0.001 respectively). Age, male sex and comorbidity, were independently associated with higher in-hospital mortality and healthcare working with lower mortality (OR 0.211, 95%CI 0.067-0.667, p = 0.008). 30-days survival was higher in HCW (0.968 vs. 0.851 p<0.001). Conclusions Hospitalized COVID-19 HCW had fewer comorbidities and a better prognosis than NHCW. Our results suggest that professional exposure to COVID-19 in HCW does not carry more clinical severity nor mortality

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

(1) Scant information is available concerning the characteristics that may favour the acquisition of COVID-19 in patients with inflammatory bowel disease (IBD). Therefore, the aim of this study was to assess these differences between infected and noninfected patients with IBD. (2) This nationwide case-control study evaluated patients with inflammatory bowel disease with COVID-19 (cases) and without COVID-19 (controls) during the period March-July 2020 included in the ENEIDA of GETECCU. (3) A total of 496 cases and 964 controls from 73 Spanish centres were included. No differences were found in the basal characteristics between cases and controls. Cases had higher comorbidity Charlson scores (24% vs. 19%; p = 0.02) and occupational risk (28% vs. 10.5%; p < 0.0001) more frequently than did controls. Lockdown was the only protective measure against COVID-19 (50% vs. 70%; p < 0.0001). No differences were found in the use of systemic steroids, immunosuppressants or biologics between cases and controls. Cases were more often treated with 5-aminosalicylates (42% vs. 34%; p = 0.003). Having a moderate Charlson score (OR: 2.7; 95%CI: 1.3-5.9), occupational risk (OR: 2.9; 95%CI: 1.8-4.4) and the use of 5-aminosalicylates (OR: 1.7; 95%CI: 1.2-2.5) were factors for COVID-19. The strict lockdown was the only protective factor (OR: 0.1; 95%CI: 0.09-0.2). (4) Comorbidities and occupational exposure are the most relevant factors for COVID-19 in patients with IBD. The risk of COVID-19 seems not to be increased by immunosuppressants or biologics, with a potential effect of 5-aminosalicylates, which should be investigated further and interpreted with caution

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio